Main Article Content



A respiratory tract infection is an infection anywhere in the respiratory tract (i.e nose, throat, lungs). The infection can be caused by bacteria, viruses or fungi. Respiratory infections are very common. They are believed to be one of the main reasons why people visit their General Physician (GP) or Pharmacist. Respiratory tract infection is of two types Upper Respiratory Tract infection and Lower Respiratory Tract infection.


To study the prescription monitoring in respiratory tract infections in a tertiary care hospital.


The data were collected in a prescribed performa from the medical case sheets, Drug charts, Laboratory investigations of 119 Inpatients. This was a prospective observational study carried out for Inpatients in Pulmonology department.


119 patients in Pulmonology department are administered with different types of antibiotics. Majorly Macrolide antibiotics are administered. Corticosteroids are administered in patients of age group 79-88 years. 60(50.4%)  patients were administered with Macrolides, 52(43.6%) were administered with Cephalosporins, 37(31.09%) patients were administered with Pencillins, 11(9.24%) were administered with Flouroquinolones, 7(5.88%) patients were administered with Tetracyclins and the rest of patients were administered with other types of  antibiotics like Carbapenems, Glycopeptides, Sulphonamides, Oxazolidines, Antimicrobials.


It was observed that the patients were prescribed rationally with antibiotics, Corticosteroids(particularly in elderly patients). A prescription based survey is considered to be one of the scientific methods to access and evaluate the rationality of the prescription for observation of drug utilization study. This observational, prospective study on drug use reflects the actual clinical practice in the communication.


Respiratory tract infection Antibiotics Prescription Rational Inpatients Pulmonology

Article Details

How to Cite
R Ragini, Shivkumar Shete, K Anoosha, P Anees, & Afshan Shadab baig. (2021). The study of prescription pattern in respiratory tract infection diseases in a tertiary care hospital. International Journal of Research in Pharmacology & Pharmacotherapeutics, 7(1), 12-19. Retrieved from


  1. [1]. National prescribing services [internet]. Australia: Department of medicine; J2012.Respiratory tract infections; 2012 [cited 2017]. Available from: individuals/what-is-tract-infections.
  2. [2]. Available from
  3. [3]. Respiratory Expert Group. Therapeutic guidelines: Respiratory; Pneumonia, Sinusitis, Influenza. Melbourne: Therapeutic Guidelines Ltd; March 2012. (Accessed 2012).
  4. [4]. Available from
  5. [5]. Available from ( American family physician )
  6. [6]. Symbicort [internet].US: AstraZeneca group of companies;Symbicort;2017 [cited 2017]. Available from https:/
  7. [7]. Tang, Benjamin M P, Craig, Jonathan C, Eslick, Guy D, et al. “Use of corticosteroids in acute lung injury and acute respiratory distress syndrome”. Journal of Critical Care Medicin. 37, 2009, 1594-1603
  8. [8]. Fendrick M.A, Arnold S.M, Nightengale B, et al. “The Economic Burden of Non– Influenza-Related Viral Respiratory Tract Infection in the United States”. Journal of the American Medical Association. 163(4), 2003, 487-494.
  9. [9]. E H Hansen. “Treatment of upper respiratory tract infections – a comparative study of dispensing and non dispensing doctors. ”Journal of Clinical Pharmacy and Therapeutics. 27(4), 2002, 289–298.
  10. [10]. C C Butler, M J Kelly, K Hood, T Schaberg, et al. “Antibiotic prescribing for discoloured sputum in acute cough/lower respiratory tract Infection.” European respiratory journal 38, 2011, 119-125.
  11. [11]. Jeffrey A Linder, MD, MPH and Daniel E Singer, MD. “Desire for Antibiotics and Antibiotic Prescribing for Adults with Upper Respiratory Tract Infections.” Journal of General Internal medicine. 18(10), 2003, 795–801.
  12. [12]. Hadley JA. “Rational use of antibiotics to treat respiratory tract infections”. American journal of managed care. 8(8), 2002, 713-27.
  13. [13]. Paul A. Mitenk , Richard I. Ogilvie. “Rational Intravenous Doses of Theophylline.” The new England journal of medicine. 289, 1973, 600-603
  14. [14]. J. Wood, C.C. Butler, K. Hood, M.J. Kelly, T. Verheij, P. Little, “Antibiotic prescribing for adults with acute cough/lower respiratory tract infection.” European Respiratory Journal 38, 2011, 112-118.
  15. [15]. Ralph Gonzales; Daniel C. Malone; Judith H. Maselli; Merle A. Sande. “Excessive Antibiotic Use for Acute Respiratory Infections in the United States.” Journal of Clinical Infectious Diseases 33(6), 2001, 757-762.
  16. [16]. Little P, Moore M, Dermontt M.L, Mulle M, stuart B. “Delayed antibiotic prescribing strategies for respiratory tract infections in primary care: pragmatic, factorial, randomized controlled trial.” British medical journal. 2014, 348.
  17. [17]. Akkerman A.E, Kuyvenhoven M.M, Wouden J, Theo JM Verheij. “Prescribing antibiotics for respiratory tract infections-management and prescriber characteristics”. British journal of general practice. 2005
  18. [18]. Woensel V.J.B.M, Aalderen van W.M.C, Weerd W, Jansen N.J.G, Van Gestel P.J, kimpen L.L, et al. “Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus”. British medical journal. 8, 2003, 383-387.
  19. [19]. Tabatabaei.A, Heidarzadeh.A, Shamspour.N, and Kolivand .P. “The Efficacy of Systemic Corticosteroids in Treatment of Respiratory Tract Infections”. Iranian Red Crescent medical journal. 17(1), 2015.
  20. [20]. JiangnanZhao, Yao Liu, and Huaichen Li “Corticosteroids in treatment of aspirationrelated acute respiratory distress syndrome: results of a retrospective cohort study.” BMC Pulm Med. 2016, 16-29.
  21. [21]. O. Sibila, C. Agustí, A. Torres. “Corticosteroids in severe pneumonia.”European respiratory journal. 32, 2008, 259-264.